Fast. Fluid. Flexible.
FORMA follows the Science.

Fast. Fluid. Flexible.
FORMA follows the Science.


FORMA advances great science through merging our ideas with those derived from a broad network of collaborative partnerships built to pursue our long term vision.

We support drug discovery and development through:

Therapeutic Areas

  • FORMA is creating medicines in therapeutic areas for people with serious diseases who will benefit profoundly from new treatment options, including:
  • Oncology

    For more details on our Oncology programs currently in clinic, please visit
  • Immuno-Oncology

  • Inflammation & Immune-Mediated Diseases

  • Neurodegenerative Diseases

Research Focus

At FORMA, our focus first on specific disease mechanisms enables a broad pipeline of multiple lead molecules advancing in parallel, with each additionally informing the progress of other projects.

Mechanisms of disease in which FORMA is identifying targets and developing potential treatments, include:

“FORMA works in uniquely collaborative internal and external frameworks to foster the advancement of science while being guided by the question of
"What If?”, which encourages us to re-imagine healthcare."

– Rob Sarisky Ph.D., M.B.A. (EVP, FORMA Ventures)

Collaborative Networks
& Tool Kits

FORMA creates integrated drug discovery teams with broad and deep capabilities in chemistry and biology to find needed medicines. We drive scientific innovation through open data exchange and an innovative Partnership Philosophy   that ensures breakthrough ideas are rapidly translated into new drug candidates.

FORMA accelerates research through:

We support drug discovery and development with significant Platform Capabilities  .



At FORMA, our collaborative research
culture, in combination with a sense of
urgency on behalf of patients, drives
seamless progress through the drug
discovery and development process,
reducing delays.

Our drug discovery and clinical development
research teams work together from start to
finish to create efficiencies that increase speed
across all research stages.

Clinical Programs

Current Clinical Trials can be found at


FORMA creates drug candidate selection criteria that foster early-stage clinical development success.

Together with our strategic partners, we prioritize drug candidates with mechanisms of action in specific patient populations, enabling us to look for early evidence of clinical response and streamline the path to regulatory approval.

The safety and efficacy of the drug candidates and their uses under investigation have not been established. There is no guarantee that the agents will receive health authority approval or become commercially available in any country for the uses being investigated.